GAPDHP31

Across TCGA pan-cancer cohorts, GAPDHP31 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated GAPDHP31 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher GAPDHP31 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated GAPDHP31 expression acts as an unfavorable survival marker, although some lineages such as READ and SKCM show a favorable association.

READ, KICH, and CHOL are the cancer types where GAPDHP31 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	II,III,IV	0.762	0.430	.006	86	view →
KICH	DFS	Tertile	II,III,IV	0.043	0.950	<.001	84	view →
CHOL	DFS	Tertile	II,III,IV	0.102	0.473	<.001	54	view →
SKCM	OS	Tertile	All	0.888	0.724	.003	24	view →
LAML	DFS	Median	All	0.276	0.631	<.001	24	view →
THCA	DFS	Tertile	IV	0.468	0.964	.001	15	view →
LUAD	OS	Tertile	All	0.762	0.829	.014	15	view →
HNSC	OS	Tertile	IV	0.638	0.327	.007	11	view →
PAAD	OS	Tertile	III,IV	0.723	1.000	.045	6	view →
ACC	OS	Median	IV	0.344	0.724	.038	6	view →
DLBC	DFS	Median	IV	1.000	0.510	.030	3	view →
KIRC	DFS	Tertile	All	0.758	0.573	.038	2	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

GAPDHP31–READ (DFS)

Open the READ breakdown →